Elliptic Laboratories ASA (ELABS): key financial figures for fiscal year 2024 (in NOK), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2024): kr 131.9M
Net Income/Loss (FY2024): kr 9.0M
Total Assets (FY2024): kr 361.0M
Total Equity (FY2024): kr 325.3M
Cash Flows from Operating Activities (FY2024): -kr 10.6M

Source: Elliptic Laboratories ASA annual_report filing (FY2024). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.

Elliptic Laboratories ASA (ELABS): key financial figures for fiscal year 2024 (in NOK), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2024): kr 131.9M
Net Income/Loss (FY2024): kr 9.0M
Total Assets (FY2024): kr 361.0M
Total Equity (FY2024): kr 325.3M
Cash Flows from Operating Activities (FY2024): -kr 10.6M

Source: Elliptic Laboratories ASA annual_report filing (FY2024). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.